SCHEMBL22554746

SCHEMBL22554746

Cc1cc(-c2ccc(-c3ccccc3)cc2)cc(Cl)c1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
CYP3A4 P08684 4/20 0.48
TDP1 Q9NUW8 3/20 0.48
TSHR P16473 3/20 0.48
TP53 P04637 1/20 0.48
ESR2 Q92731 1/20 0.46
CYP1A2 P05177 2/20 0.41
HSD17B10 Q99714 2/20 0.41
TAAR1 Q96RJ0 1/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
CYP1A1 P04798 1/20 0.41
BRD4 O60885 1/20 0.41
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40
LMNA P02545 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38
GLA P06280 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22554699 0.86 ALDH1A1 (0.67) ALDH1A1CYP3A4TDP1TSHRTP53
SCHEMBL1392591 0.85 CYP3A4 (0.65) ALDH1A1CYP3A4TDP1TSHRTP53
SCHEMBL3827276 0.83 ESR2 (0.50) ALDH1A1CYP3A4TDP1TSHRESR2
SCHEMBL807863 0.83 ALDH1A1 (0.70) ALDH1A1CYP3A4TDP1TSHRTP53
SCHEMBL22554727 0.81 ALDH1A1 (0.67) ALDH1A1CYP3A4TDP1TSHRTP53
SCHEMBL22554778 0.78 ALDH1A1 (0.50) ALDH1A1CYP3A4TDP1TSHRTP53
SCHEMBL1918559 0.78 ALDH1A1 (0.54) ALDH1A1CYP3A4TDP1TSHRTP53
SCHEMBL8954034 0.76 ALDH1A1 (0.82) ALDH1A1CYP3A4TDP1TSHRTP53
SCHEMBL22517389 0.76 ALDH1A1 (0.52) ALDH1A1CYP3A4TDP1TSHRTP53
SCHEMBL7246163 0.76 CYP2A6 (0.46) ALDH1A1CYP3A4TDP1ESR2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111825558-B Novel compound and organic light-emitting device 乐金显示有限公司 2024-05-03 CN disclosed
US-11844270-B2 Compound and organic light emitting device including the same LG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11844270-B2 Compound and organic light emitting device including the same LG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11844270-B2 Compound and organic light emitting device including the same LG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
CN-111825558-A Novel compound and organic light-emitting device 乐金显示有限公司 2020-10-27 CN disclosed
US-20200335698-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE LG DISPLAY CO., LTD. (KR) 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11844270-B2 Compound and organic light emitting device including the same TMEM109, CRY1, VDAC1 ALDH1A1 54/4885CYP3A4 212/4885TDP1 1190/4885
US-20200335698-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE TMEM109, TRPC1, MAP1LC3B ALDH1A1 155/4885CYP3A4 436/4885TDP1 1643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.